Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China · Delayed Price · Currency is CNY 5.94
-0.05 (-0.83%)
Sep 10, 2026, 3:00 PM CST
SHA:605199 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 38.91 | 78.21 | 254.29 | 522.69 | 480.37 | 487.68 |
Cash & Short-Term Investments | 38.91 | 78.21 | 254.29 | 522.69 | 480.37 | 487.68 |
Cash Growth | -76.94% | -69.24% | -51.35% | 8.81% | -1.50% | 41.00% |
Accounts Receivable | 368.59 | 426.72 | 416.74 | 469.77 | 453.68 | 355.42 |
Other Receivables | 38.19 | 20.23 | 2.81 | 6.3 | 2.92 | 4.18 |
Receivables | 406.77 | 446.95 | 419.55 | 476.06 | 456.6 | 359.6 |
Inventory | 206.4 | 254.34 | 446.77 | 280.5 | 213.56 | 213.23 |
Other Current Assets | 88.2 | 101.81 | 98.87 | 63.28 | 96.73 | 26.32 |
Total Current Assets | 740.29 | 881.3 | 1,219 | 1,343 | 1,247 | 1,087 |
Property, Plant & Equipment | 1,378 | 1,412 | 1,381 | 1,263 | 802.62 | 529.36 |
Long-Term Investments | 15.51 | 16.68 | 18.42 | 20.44 | 20.1 | - |
Goodwill | - | - | 12.11 | 12.11 | - | - |
Other Intangible Assets | 185.86 | 192.05 | 182 | 160.05 | 102.36 | 113.99 |
Long-Term Deferred Tax Assets | 11.05 | 10.42 | 13.56 | 8.33 | 5.1 | 8.12 |
Long-Term Deferred Charges | 87.43 | 86.63 | 95.18 | 87.84 | 55.55 | 22.63 |
Other Long-Term Assets | 0.88 | 3.76 | 41.86 | 44.95 | 79.08 | - |
Total Assets | 2,419 | 2,603 | 2,964 | 2,939 | 2,312 | 1,761 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 549.18 | 539.97 | 404.37 | 194.16 | 139.92 | 44.75 |
Accrued Expenses | 43.08 | 66.46 | 41.87 | 38.65 | 48.16 | 145.99 |
Short-Term Debt | 374.24 | 433.88 | 411.32 | 420.62 | 500.95 | 438.98 |
Current Portion of Long-Term Debt | 169.08 | 70.78 | 262.17 | 118.52 | 0.13 | 52.08 |
Current Portion of Leases | - | 121.35 | 41.95 | 2.98 | 4.5 | 4.05 |
Current Income Taxes Payable | 15.01 | 0.26 | 1.19 | 9.4 | 2.13 | 1.28 |
Current Unearned Revenue | 42.27 | 74.88 | 126.87 | 120.42 | 262.18 | 66 |
Other Current Liabilities | 261.76 | 133.81 | 148.33 | 152.33 | 98.93 | 40.81 |
Total Current Liabilities | 1,455 | 1,441 | 1,438 | 1,057 | 1,057 | 793.95 |
Long-Term Debt | 505.05 | 545.4 | 589.54 | 737.43 | 177.61 | - |
Long-Term Leases | 0.79 | 44.77 | 93.81 | 2.07 | 0.79 | 4.1 |
Long-Term Unearned Revenue | 110.55 | 111.16 | 96.92 | 76.23 | 61.5 | 32.36 |
Long-Term Deferred Tax Liabilities | 2.06 | 2.21 | 2.6 | 2.95 | - | - |
Other Long-Term Liabilities | 0.24 | - | 0.18 | - | - | - |
Total Liabilities | 2,073 | 2,145 | 2,221 | 1,876 | 1,297 | 830.41 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 400.11 | 400.11 | 400.11 | 400.11 | 400.11 | 400.11 |
Additional Paid-In Capital | 290.56 | 290.56 | 290.56 | 290.56 | 290.56 | 290.56 |
Retained Earnings | -391.57 | -278.18 | 9.2 | 334.07 | 323.21 | 237.53 |
Comprehensive Income & Other | - | 0.21 | 0.28 | - | - | - |
Total Common Equity | 299.11 | 412.7 | 700.16 | 1,025 | 1,014 | 928.21 |
Minority Interest | 46.54 | 45.32 | 42.35 | 38.99 | 1.38 | 2.32 |
Shareholders' Equity | 345.65 | 458.02 | 742.5 | 1,064 | 1,015 | 930.52 |
Total Liabilities & Equity | 2,419 | 2,603 | 2,964 | 2,939 | 2,312 | 1,761 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,049 | 1,216 | 1,399 | 1,282 | 683.98 | 499.21 |
Net Cash (Debt) | -1,010 | -1,138 | -1,145 | -758.92 | -203.61 | -11.53 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -2.10 | -2.85 | -2.88 | -2.10 | -0.50 | -0.03 |
Filing Date Shares Outstanding | 396.23 | 400.11 | 400.11 | 400.11 | 400.11 | 400.11 |
Total Common Shares Outstanding | 396.23 | 400.11 | 400.11 | 400.11 | 400.11 | 400.11 |
Working Capital | -714.34 | -560.09 | -218.6 | 285.45 | 190.37 | 292.88 |
Book Value Per Share | 0.75 | 1.03 | 1.75 | 2.56 | 2.53 | 2.32 |
Tangible Book Value | 113.24 | 220.66 | 506.05 | 852.58 | 911.53 | 814.21 |
Tangible Book Value Per Share | 0.29 | 0.55 | 1.26 | 2.13 | 2.28 | 2.03 |
Buildings | - | 1,010 | 905.11 | 353.33 | 318.42 | 304.62 |
Machinery | - | 595.17 | 531.48 | 306.73 | 273.68 | 273.15 |
Construction In Progress | - | 191.53 | 252.92 | 873.63 | 433.13 | 149.69 |